California-based AI biotechnology company Terray Therapeutics has launched with USD 60 million Series A funding led by Madrona Venture Group. Existing investors Two Sigma Ventures and Digitalis Ventures—who led the company’s unannounced USD 20 million seed funding round in June 2021—and several new investors also participated in the round.
The proceeds will be directed toward progressing the company’s preclinical therapeutic pipeline and scaling its partnerships.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.